Int J Obes 2025
Well-tolerated with favorable safety profile
A total of 10 patients at UBs Clinical Research Center in the Division of Endocrinology were studied from 2020-22, all of whom had been diagnosed in the past three to six months with Type 1 diabetes
The evidence here is observational, so it should be treated as a risk cue, not a proven mechanism
Generationally, 7% were baby boomers, 29% were Gen X, 44% were millennials, and 19% were Gen Z
Per a 2021 analysis published in Diabetes Obesity Metabolism , nearly 50% of patients on semaglutide report nausea.41 Side effects tend to be dose dependent and may lessen in intensity with ongoing treatment.42,43 An underlying cause for these GI complaints relates to one of the ways in which GLP-1 medications work, which involves delayed gastric emptying